David HoAug 4, 2024

Unfortunately, the drug that prevents HIV infection, lenacapavir, is currently unaffordable at $42,250 for the first year. If it were sold by Gilead for $40 per year, it would still yield them a 30% profit. But I guess that’s not how capitalism works.

https://www.nature.com/articles/d41586-024-02493-4

Stunning trial shows twice-yearly shots can prevent HIV infection

Injections of the drug lenacapavir protected sexually active women and girls in Africa from the virus.

Show threadAshAug 4, 2024
@davidho there should be a profit limit of 50% or smth. Atleast in essential stuff.
Show threadMoté
@45h @davidho in France, selling price is determined by an agreement between the pharmaceutical laboratory and the sanitory agency. There are multiple drugs that still can't be sold because they couldn't reach to an agreement even after years of negotiations.
Aug 4, 2024 at 5:46pmWeb
Show threadPeter BrownAug 5, 2024
@petitmote @45h @davidho same in UK and presumably in every other developed country in the world who unlike the USA all have a universal health service.